These data would suggest that people with schizophrenia who have lower levels of CHRM1 could, as has previously been suggested (Egan et al., 2001), have cognitive deficits that are at least in part due to a breakdown in homeostasis in pathways regulated by COMT. The gene discussed is CHRM1; the disease is Cognitive impairment.